• Subscribe
  • Newsfeed
  • About
  • Jobs
AI Search
Announce News

TRIMTECH Therapeutics

To add a bio or update company history, please click update information.

News from TRIMTECH Therapeutics

    TRIMTECH raises £24m seed led by Cambridge Innovation Capital and SV Health Investors to advance neurodegenerative treatmentsTRIMTECH raises £24m seed led by Cambridge Innovation Capital and SV Health Investors to advance neurodegenerative treatments
    TRIMTECH Therapeutics
    5 Mar 2025

    TRIMTECH raises £24m seed led by Cambridge Innovation Capital and SV Health Investors to advance neurodegenerative treatments

    TRIMTECH Therapeutics develops targeted protein degradation medicines that selectively remove harmful protein aggregates, focusing on neurodegenerative and inflammatory diseases with limited existing treatment options.

TRIMTECH Therapeutics
  • Life Sciences
  • Cambridge, United Kingdom
  • £24m
  • trimtechtherapeutics.com
  • Update Information

More venture news

  • Semarion secures £2.9m in funding led by Parkwalk to accelerate cell-based drug discovery
    Semarion
    31 Mar 2026

    Semarion secures £2.9m in funding led by Parkwalk to accelerate cell-based drug discovery

    EquityLife Sciences

Sign-up to our newsletter

The UK Weekly email covers every VC round from last week, firms that are hiring, and much more

Soapbox Ventures Limited © 2026

Disclaimer

Privacy Policy

LinkedIn

Announce

  • Share your story

General

  • Read the latest
  • About Soapbox

Information not up to date?

Get in touch

Soapbox Ventures Limited © 2026

Disclaimer

Privacy Policy

LinkedIn